How an Implanted Sensor Checks Its Own Accuracy Over Time
This patent describes a method for an electronic device to continuously monitor and evaluate how well an implanted medical sensor, like a glucose sensor, is working by tracking changes in its accuracy over time.
Patent Number
US 10052055
Status
Active
Filing Date
November 5, 2013
Grant Date
August 21, 2018
Expiration
November 5, 2033
Claims
15
Assignee
Dexcom
Inventors
Ying Li, Mark C. Brister, Apurv Ullas Kamath, Richard C. Yang
Citations
15 forward · 679 backward
What it covers
The patent describes a method for an electronic device to check if an implanted sensor, such as one measuring glucose, is still accurate. It works by first "receiving sensor data from an analyte sensor implanted in a host" (Claim 1). Next, the device "intermittently calculat[es] a sensitivity of the analyte sensor" (Claim 1). Sensitivity here refers to how effectively the sensor converts the measured substance into a signal. Finally, the device "evaluat[es], using an electronic device, a change in sensitivity by evaluating a plurality of time-spaced sensitivity calculations over a predetermined time period" (Claim 1). This evaluation uses "a priori sensitivity information" to create an "expected sensitivity profile that is a function of time" (Claim 1). For example, if a glucose sensor's accuracy typically drops after 5 days, the system uses this known pattern to better interpret current sensitivity changes.
What it doesn't cover
- —Does not cover systems that only measure analyte values without also evaluating changes in the sensor's sensitivity.
- —Does not cover sensors that are not implanted in a host's body.
- —Does not cover methods that do not use "a priori sensitivity information" to generate an "expected sensitivity profile."
- —Does not cover systems that only calculate sensitivity once, rather than "intermittently" and evaluating "a plurality of time-spaced sensitivity calculations."
- —Does not cover systems that do not use an electronic device to perform the sensitivity evaluation.
The clever bit
The clever part is using "a priori sensitivity information" – basically, knowing how a sensor's accuracy typically changes over its lifespan – to create an "expected sensitivity profile." This allows the system to not just detect a change in sensitivity, but to evaluate it against a known pattern, making the accuracy assessment more intelligent and predictive.
Why it matters
For people managing conditions like diabetes, the accuracy of continuous glucose monitors (CGMs) is crucial. This patent addresses a key challenge: how sensor accuracy can change over time once implanted. By continuously evaluating and potentially correcting for these changes, it helps ensure that patients and their doctors receive reliable data, leading to better health decisions and improved safety.
Real-world examples
- 1.Dexcom G6 Continuous Glucose Monitoring System
- 2.Dexcom G7 Continuous Glucose Monitoring System
- 3.Other continuous glucose monitoring (CGM) devices that adjust for sensor drift
Generated by PatentBrief · Not legal advice · patentbrief.org
US 10052055 · 2026